ClinicalTrials.gov 临床试验·· 16 小时前精选AI 评分50
康替唑胺前药与康替唑胺对比利奈唑胺治疗中重度糖尿病足感染的3期研究
Safety and Efficacy Study of Contezolid Acefosamil and Contezolid Compared to Linezolid Administered Intravenously and Orally to Adults With Moderate or Severe Diabetic Foot Infections (DFI)
AI 导读
ClinicalTrials.gov登记了一项3期、多中心、随机、双盲研究，评估contezolid acefosamil（静脉给药）/contezolid（口服）对比linezolid（静脉和口服）在中重度糖尿病足感染（DFI）成人受试者中的安全性和有效性，给药总疗程为14至28天。
来源：ClinicalTrials.gov 临床试验 · clinicaltrials.gov